Advertisement
Anbio Biotechnology Class... (NNNN)
NASDAQ: NNNN
· Real-Time Price · USD
6.49
0.06 (0.93%)
At close: Apr 29, 2025, 11:20 AM
0.93% (1D)
| Bid | 6.4 |
| Market Cap | 284.85M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | 0.03 |
| PE Ratio (ttm) | 216.33 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 6.9 |
| Volume | 5,493 |
| Avg. Volume (20D) | 161,993 |
| Open | 6.32 |
| Previous Close | 6.43 |
| Day's Range | 6.32 - 6.69 |
| 52-Week Range | 5.18 - 7.82 |
| Beta | 0.00 |
About NNNN
Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves o...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Feb 19, 2025
Employees NaN
Stock Exchange NASDAQ
Ticker Symbol NNNN
Website https://www.anbio.com
Advertisement
2 months ago · seekingalpha.com
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small ListingsThe calendar slowed down this past week, with only small listings in the US. There was one sizable filing this past week - AIRO Group Holdings. No IPOs are currently scheduled to list in the week ahea...